论文部分内容阅读
目的探讨手足口病临床治疗要点,以及采用炎琥宁联合利巴韦林治疗手足口病的效果。方法研究选取我院在2011年3月至2012年9月收治的100例手足口病患者,所有患者都自愿接受调查和服从所有准则,将这些患者作为研究对象并随机分为观察组和对照组。在观察组中,对患者给予炎琥宁联合利巴韦林治疗,在对照组中,对患者给予常规性治疗。观察两组患者在采用不同治疗治疗方案后,患者的体温恢复时间,疗程以及皮疹消退时间,并将所得到的自己进行对比分析研究。结果在患者的体温恢复时间,疗程以及皮疹消退时间方面,观察组和对照组具有本质上差异,差异具有统计学意义。结论加强对小儿手足口病临床观察,对临床症状的分析以及采用炎琥宁联合利巴韦林治疗手足口病是提高临床疗效关键措施。
Objective To explore the clinical treatment of hand, foot and mouth disease, as well as the use of Yan Hu Ning combined with ribavirin in the treatment of hand, foot and mouth disease results. METHODS: A total of 100 HFMD patients admitted to our hospital from March 2011 to September 2012 were enrolled in this study. All patients were volunteered to be surveyed and obeyed all criteria. All patients were randomly divided into observation group and control group . Patients in the observation group were treated with both Yan Hu Ning and ribavirin, and in the control group patients were given routine treatment. Observe the two groups of patients in different treatment options, the patient’s body temperature recovery time, treatment and rash subsided time, and the resulting self-comparative study. Results There were significant differences between the observation group and the control group in terms of time of body temperature recovery, duration of treatment and rash subsidence, the difference was statistically significant. Conclusion To strengthen the clinical observation of hand-foot-mouth disease in children, analysis of clinical symptoms and treatment of hand-foot-mouth disease with combination of Yan Hu-Ning and ribavirin are the key measures to improve clinical curative effect.